2016
DOI: 10.1038/srep36814
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of pathological response to therapy using lipid mass spectrometry imaging

Abstract: In many cancers, the establishment of a patient’s future treatment regime often relies on histopathological assessment of tumor tissue specimens in order to determine the extent of the ‘pathological response’ to a given therapy. However, histopathological assessment of pathological response remains subjective. Here we use MALDI mass spectrometry imaging to generate lipid signatures from colorectal cancer liver metastasis specimens resected from patients preoperatively treated with chemotherapy. Using these sig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 56 publications
0
23
0
Order By: Relevance
“…Data were analysed with a user-independent, unbiased statistical approach, which is called unsupervised cluster analysis 23 , 24 . Tissue was segmented into regions (clusters) based on multivariate molecular patterns, which were present in the metabolomics data 25 , 26 . Segmentation of the data into 6 clusters resulted in separation of the predicted ischemic region into a separate cluster as early as 15 min of ischemia and also at all the other ischemic times (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Data were analysed with a user-independent, unbiased statistical approach, which is called unsupervised cluster analysis 23 , 24 . Tissue was segmented into regions (clusters) based on multivariate molecular patterns, which were present in the metabolomics data 25 , 26 . Segmentation of the data into 6 clusters resulted in separation of the predicted ischemic region into a separate cluster as early as 15 min of ischemia and also at all the other ischemic times (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Until now, MALDI IMS was used to characterize responses in diseases with evident tissue pathology (e.g. cancer and others) 5 , 26 . Our finding confirms that MALDI IMS can detect molecular perturbations even in absence of evident histological lesions (ischemic period ≤ 30 min).…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, most of LPC inversely correlated with the resistant score. Previous studies have shown that breast and lung cancer cells are characterized by important quantitative and qualitative alterations of lipid concentrations in the plasma membrane, highlighting the ability to adapt to different environmental conditions to ensure proliferation and survival (Cifkova et al, 2015;Hilvo et al, 2011;Marien et al, 2015;Patterson et al, 2016). Moreover, lipid composition of the plasma membrane plays a critical role in the delivery of anticancer drugs to reach their intracellular targets via passive diffusion or active transport (Alves et al, 2016;Peetla et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, in order to determine whether the molecular distributions correlate with the cancer region in the tissue section, and to further verify if the predicted DESI MSI has greater performance in the mining of biomarker compounds, the receiver operating characteristic (ROC) curves were plotted for each raw molecular image ( Supplementary Figure 9). ROC curve is a binary classifier and have been profoundly used in evaluating test for detections of cancers over the past decades [48][49][50][51] . In our study, spatial-chemical results of the metastatic lung section obtained by DESI MSI were compared with the pathological evaluations.…”
Section: Validations Of Predicted Msimentioning
confidence: 99%